Market Research Insights

San Francisco, 20 September 2019:   The Report   Ovarian Cancer Drugs Market   Size, Share & Trends Analysis Report By Therapeutic Class (PARP, PD-L1, Angiogenesis Inhibitors) , By Major Markets (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 – 2022 The global ovarian cancer drugs market size is expected to be valued at USD 4.5 billion by 2022, as per a new report by Grand View Research, Inc., expanding at a CAGR of 23.7% during the forecast period. The growth of the market is largely driven by factors such as increased adoption of novel drugs and presence of strong pipeline. Rising incidence of ovarian cancer due to growing geriatric population and unhealthy lifestyles is providing an upthrust to the market. Ovarian cancer accounts for 3.0% of all malignant tumors among women and 6.0% of all femaledeaths due to cancer. Ovarian cancer accounted for 235,200 new cases and 140,000 deaths worldwide in 2016 with the highest incidence being reported i

San Francisco, 20 September 2019:   The Report   Nanomedicine Market   Analysis By Products, (Therapeutics, Regenerative Medicine, Diagnostics), By Application, (Clinical Oncology, Infectious diseases), By Nanomolecule (Gold, Silver, Iron Oxide, Alumina), & Segment Forecasts, 2018 – 2025 The global nanomedicine market is anticipated to reach USD 350.8 billion by 2025, according to a new report by Grand View Research, Inc. Development of novel nanotechnology-based drugs and therapies is driven by the need to develop therapies that have fewer side effects and that are more cost-effective than traditional therapies, in particular for cancer. Application of nanotechnology-based contrast reagents for diagnosis and monitoring of the effects of drugs on an unprecedented short timescale is also attributive drive growth in the coming years. Additionally, demand for biodegradable implants with longer lifetimes that enable tissue restoration is anticipated to influence demand. As per t

San Francisco, 20 September 2019:   The Report   Smart Syringes Market   Analysis by Therapeutic Category (Auto-Disable Syringes, Active Safety Syringes, Passive Safety syringes), By Application (Drug delivery, Vaccination, Blood Specimen Collection), By End-use (Hospitals and HMOs, Diabetic Patients, Family Practices (Physicians), Psychiatrists) And Segment Forecasts To 2024 The global smart syringes market is expected to reach USD 10.2 billion in 2024, according to a new report by Grand View Research, Inc. In 2015, Some key factors driving the market include the rise in the patient population, the increasing number of needle stick injuries, and the spread of diseases due to unhygienic injection practices. The injection practices and healthcare delivery standards are not uniform across the globe. The use of disposable syringes has been strongly advocated by various healthcare organizations across different countries; however, adherence to the patient safety guidelines is not adeq

San Francisco, 20 September 2019:  The Report   Endocrine Testing Market   Size, Share & Trends Analysis Report By Test Type, By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use And Segment Forecasts, 2018 – 2024 The global endocrine testing market is expected to reach USD 13.02 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population and growing rate of diseases such as obesity and diabetes is expected to drive the market growth. The presence of a large population over 60 years, having lower immunity levels and are prone to neurological diseases, cardiac problems, cancers, and spinal injuries, is a high impact-rendering driver for the growth of endocrine testing market over the forecast period. Sedentary lifestyles of people with unhealthy food habits and increasing stress levels resulted in an increase in the diabetic and obese population. This demographic is highly susceptible to endocrine diseases and is antici

San Francisco, 20 September 2019:   The Report   Coagulation Analyzer Market  Analysis By Product, By Technology (Mechanical, Electrochemical) By Test Types (APTT, D-Dimer, Fibrinogen, PT) By End Use (Hospitals, Research Institutes) & Segment Forecasts, 2018 – 2024 The global coagulation analyzers/reagents market is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years. The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunolo

San Francisco, 19 September 2019:   The Report   Anesthesia CO2 Absorbent Market ,  By Product (Soda Lime, Medisorb, Dragersorb, Amsorb, Litholyme), Market Size, Application Analysis, Competitive Strategies and Forecasts, 2012 – 2022 Global Anesthesia CO2 Absorbent Market is expected to reach USD 79.1 million by 2022, according to a new report by Grand View Research, Inc. Rising geriatric population, increasing usage of regional anesthesia, and augmenting volume of surgical procedures across the globe are vital impact rendering drivers for the market. Anesthesia CO 2  absorbent forms a niche segment within the anesthesia disposables, the demand for which is expected to rise with increasing number of surgeries. According to the statistics provided by the WHO in collaboration with the Department of Health Policy and Management of Harvard, the global surgical volume is high and accounts for about 234 million surgeries per year. Furthermore, with this increase, a proportional rise i

San Francisco, 19 September 2019:   The Report   Intravenous Immunoglobulin (IVIG) Market   Size, Share & Trend Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Route of Administration, And Segment Forecasts, 2012 – 2022 Global intravenous immunoglobulin market is expected to reach USD 10.9 billion by 2022, according to a new study by Grand View Research, Inc. The increasing prevalence of immunodeficiency diseases coupled with the adoption of IVIG therapies is expected to fuel market growth over the forecast period. In addition, increasing off-label use of immunoglobulin and investments in the healthcare sector are factors propelling market growth. Moreover, increasing incidences of bleeding disorders and rising geriatric population base are the factors attributing towards the industry growth. The rising incorporation of subcutaneous immunoglobulin in the treatment of primary immunodeficiency diseases and in replacement therapy is anticipated